Rumiantsev D O, Piotrovskiĭ V K, Riabokon' O S, Metelitsa V I
Farmakol Toksikol. 1987 Jan-Feb;50(1):85-9.
Verapamil concentrations were measured in the samples of blood serum and saliva taken at the same time in patients with angina of effort within 0.5-24 hr after administration of a single dose of the drug (14 persons) or the last dose of the course (10 persons). A mean ratio of saliva verapamil concentration to blood serum concentration was 0.85 +/- 0.09 (from 0.19 to 2.69) after a single administration and 0.77 +/- 0.04 (from 0.29 to 1.09) after the course treatment. A statistically significant (p less than 0.001) positive correlation was revealed between verapamil concentrations in blood serum and saliva after a single administration (r = 0.69) and course treatment (r = 0.80). It is suggested that determination of verapamil concentration in the saliva of patients on long-term verapamil medication should be used for a reference estimation of its level in the blood.
在14例单剂量服用药物或10例服用完疗程最后一剂药物后0.5 - 24小时内,对劳力性心绞痛患者同时采集的血清和唾液样本中的维拉帕米浓度进行了测量。单次给药后,唾液中维拉帕米浓度与血清中维拉帕米浓度的平均比值为0.85±0.09(范围为0.19至2.69),疗程治疗后该比值为0.77±0.04(范围为0.29至1.09)。单次给药后(r = 0.69)和疗程治疗后(r = 0.80),血清和唾液中维拉帕米浓度之间均显示出具有统计学意义(p < 0.001)的正相关。建议对于长期服用维拉帕米的患者,测定其唾液中维拉帕米浓度可作为血液中维拉帕米水平的参考估计。